• Emfo LLC Lowers Position in Pfizer Inc. (NYSE:PFE)

    Emfo LLC lessened its position in Pfizer Inc. (NYSE:PFE – Free Report) by 54.5% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 3,221 shares of the biopharmaceutical company’s stock after selling 3,860 shares during the quarter. Emfo LLC’s holdings in Pfizer […]

  • 1 Top Growth Stock Down 63% to Buy Right Now

    Is it really possible that a stock down 63% is worth buying today? Does that mean the investing community is getting something wrong? Toast (NYSE: TOST) stock is reporting strong growth metrics, but its stock has plummeted. Let’s see why it has been declining, what investors might be missing, and its plunging price could be

    • Deals

    Top-of-the-Line BLUETTI Portable Power Station, Save $600

    The BLUETTI AC200L Portable Power Station is not just about power in your hands; it is about the strength of advanced technology that brings comfort and convenience right to your doorstep. Now, it is available with a whopping 30% discount on Walmart, making it the perfect time to grab this high-end power station! With an upgraded output of 2400W, the AC200L is the formidable choice for your power needs. It exceeds its predecessor AC200MAX by 200W, further surpassing it with a unique feature of...

    • CNBC

    Top Wall Street analysts like these 3 stocks for their growth prospects

    TipRanks' analyst ranking service highlights Wall Street's best-performing stocks, including Amazon and BJ's Wholesale Club.

  • Key takeaways from Forrester’s Top Trends in IoT Security 2024

    Forrester identifies nine trends around IoT devices, which continue to be among the most vulnerable endpoints due to their very design.

  • Study: Many cancer drugs remain unproven 5 years after approval

    The U.S. Food and Drug Administration’s accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients’ lives?

  • New study paves the way for precision drugs to treat blood cancers

    The Janus kinase 2 (JAK2) protein mediates signaling from several cytokine receptors in the regulation of hematopoiesis and immune responses. Somatic mutations in human JAK2 lead to constitutive activation and cytokine-independent signaling and underlie several hematological malignancies from myeloproliferative neoplasms (MPN) to acute leukemia and lymphomas. JAK2 contains an active kinase domain and an inactive pseudokinase domain. Interestingly, pathogenic mutations mainly occur in the...

  • Beyond the hype: Enterprises embrace Gen AI as key enabler for growth

    A survey by Writer reveals CIOs overwhelmingly believe gen AI will be a key enabler for business growth and that the technology is not a fad.

  • No Rice, no Saka no problem: Arsenal go top without key men

    This was the answer to the question of whether Arsenal could function without Declan Rice or Bukayo Saka in their team. It was the first Premier League game this season with neither of them starting but Mikel Arteta’s side cruised back to the top of the table.]]>

  • How do trees survive dry and hot summers? Leaf lifespan and growth recovery are key

    Climate change has an effect on forests and trees. They suffer from heat waves and periods of drought. But although we see tree mortality increase as a result, much is still unknown about the underlying mechanisms.

  • Pfizer Inc. (NYSE:PFE) Position Lowered by Physicians Financial Services Inc.

    Physicians Financial Services Inc. decreased its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 13.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 44,018 shares of the biopharmaceutical company’s stock after selling 6,780 shares during the period. Physicians Financial Services Inc.’s holdings […]

  • New protein imaging method supports the design of innovative new cancer drugs

    Scientists have successfully used a new imaging technique to determine the structure and interactions of a protein complex that plays a significant part in the initiation and progression of cancer. They showed that it was possible to use a high-resolution form of cryogenic electron microscopy (cryo-EM) to gain a better insight into how the protein complex binds to inhibitor drug molecules.